Theranos, which promised a diagnostics revolution, and founder charged with fraud, do antidepressants work, what are Novichok nerve agents and did Russia do it? and other interesting reads from the past week.

General

The seven biggest lies Theranos told. Link

Which companies are profiting most from the U.S. healthcare system? Link

Bill of the month: for Toenail Fungus, a $1,500 prescription. Link

Google's parent company has filed 186 health care patents. Link

One-dose flu drug Xofluza gets nod from health ministry. Link

French biotech takes its oral diabetes drug to Phase III. Link

China plans to move the CFDA into a new agency. Link

Digital Health

Virtual reality could be your next painkiller. Link

Tech companies are targeting heart disease — here’s how. Link

Research

What’s behind many mystery ailments? Genetic mutations, study finds. Link

Novartis, UNC study suggests mRNA structures are a common, untapped pool of drug targets. Link

Contact lenses that deliver drugs directly to the eye win health care prize. Link

Scientists trick the brain into sensing the movement of a prosthetic. Link

Perspective and Opinions

The first AI disruption in medicine might not be radiology. Link

Do antidepressants work? Link

Interesting

What are Novichok nerve agents and did Russia do it? Link

Art and Medicine, an uncommon union?

Startups of the Week

Vectorious

The Tel Aviv-based company has developed V-LAP, a miniature, minimally invasive implant for left-atrial monitoring. Raised $9.5 million in Series B round.

Eight

Eight merges hardware and software and leverages machine learning to extract information from data to create sleelp enhancement products. Raised $14M in Series B financing.

Foghorn Therapeutics

Foghorn uses a proprietary product platform to discover and develop treatments for cancer and other serious diseases by based on novel insights into the chromatin regulatory system. Raised $50M in funding.